Pfizer Korea sponsors symposia on Detrusitol SR

Published: 2004-10-18 06:56:00

Updated: 2004-10-18 06:56:00

Pfizer Korea said it has sponsored its launching symposium concerning Detrusitol (L-tolterodine tartrate) SR using a double-capsule DDS formulation, which is used to relieve urinary difficulties, including frequent urination and inability to control urination. Tolerodine is in a class of medications called antimuscarinics.

The symposium, titled Pharmacological Management of OAB: Identifying ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.